Drug Profile


Alternative Names: BNP-166; Cronaze; Ethinase; Etiprednol Dicloacetate; Respicort

Latest Information Update: 16 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator IVAX Corporation
  • Class Anti-inflammatories; Corticosteroids; Small molecules
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Allergic rhinitis; Asthma; Crohn's disease; Ulcerative colitis

Most Recent Events

  • 16 Jan 2007 Discontinued - Phase-I for Allergic rhinitis in USA (unspecified route)
  • 16 Jan 2007 Discontinued - Phase-II for Asthma in USA (Inhalation)
  • 16 Jan 2007 Discontinued - Phase-II for Crohn's disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top